Trials of anti-chlamydial therapy - Emerging role of antibiotics in atherosclerosis

被引:8
作者
Gurfinkel, EP [1 ]
Bozovich, G [1 ]
机构
[1] Fdn Favaloro, Coronary Care Unit, RA-1093 Buenos Aires, DF, Argentina
关键词
D O I
10.1016/S0002-8703(99)70295-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It has been shown that plaque composition changes significantly in the setting of acute events, macrophages and T cells being the predominant pattern at the immediate site of fissure or erosion. There appears to be a relation between physical blood stream factors, plaque morphology, and the distribution of inflammatory cells. Furthermore, there is cumulative evidence for the presence of intracellular pathogens in the arterial wall, namely Chlamydia pneumoniae and cytomegalovirus, which affect endothelial cells, monocytes, and macrophages. The ROXIS trial has shown some encouraging evidences for the potential role of intracellular pathogens in acute coronary syndromes. The ongoing WIZARD trial evaluates in a large population whether the addition of an antibiotic provides better outcome for coronary patients.
引用
收藏
页码:S537 / S538
页数:2
相关论文
共 21 条
[21]   A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents [J].
Schomig, A ;
Neumann, FJ ;
Kastrati, A ;
Schuhlen, H ;
Blasini, R ;
Hadamitzky, M ;
Walter, H ;
ZitzmannRoth, EM ;
Richardt, G ;
Alt, E ;
Schmitt, C ;
Ulm, K .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (17) :1084-1089